SERA PROGNOSTICS, INC.
SERA · Nasdaq · SIC 8071: Services-Medical Laboratories
Business Summary
4 Item 1A. Risk Factors 42 Item 1B. Unresolved Staff Comments 84 Item 1C. Cybersecurity 84 Item 2. Properties 86 Item 3. Legal Proceedings 86 Item 4. Mine Safety Disclosures 86 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 87 Item 6. [ Reserved ] 87 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 88 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 97 Item ...
Next Earnings
Q2 FY2026 — expected 2026-09-05
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | SERA | discussed_in_filing Cybersecurity | |
| topic_mention | SERA | discussed_in_filing Cybersecurity | |
| topic_mention | SERA | discussed_in_filing Cybersecurity | |
| topic_mention | SERA | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-18 | 2025-12-31 | 0001534969-26-000009 | EDGAR | 94K words |
| 2025-03-19 | 2024-12-31 | 0000950170-25-042017 | EDGAR | — |
| 2024-03-20 | 2023-12-31 | 0001534969-24-000055 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0001534969-23-000030 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001534969-22-000034 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280182 | EDGAR | 59K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104007 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065667 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122312 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001534969-24-000152 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001534969-24-000085 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001534969-23-000112 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001534969-23-000092 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001534969-23-000051 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001534969-22-000130 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001534969-22-000123 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001534969-22-000068 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-18 | 0001534969-26-000008 | EDGAR | 3K words |
| 2026-01-08 | 0001193125-26-007850 | EDGAR | — |
| 2026-01-07 | 0001193125-26-005531 | EDGAR | — |
| 2025-11-24 | 0001193125-25-292074 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280167 | EDGAR | — |
| 2025-09-05 | 0001534969-25-000005 | EDGAR | — |
| 2025-08-06 | 0000950170-25-103994 | EDGAR | — |
| 2025-06-05 | 0000950170-25-082539 | EDGAR | — |
| 2025-05-08 | 0000950170-25-067231 | EDGAR | — |
| 2025-05-07 | 0000950170-25-065654 | EDGAR | — |
79 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001534969 |
| Ticker | SERA |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 3992a3fc8ac0b8f85be24e1fb2c3d2f0152b0a995872eb3d0908c564fdaf4504
parent: 524f6d3bbcbb0d50bcf36c39c8543c2e3bfd9e025aede0ebc61c619a04b7c896
content hash: ff764f4b8b04b602f301abeefe2be0bffcd1b30a91754f55571dd037efc44713
signed: 2026-04-13T04:47:23.332Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf